Acerand Therapeutics (Hong Kong) Limited
1 clinical trials · Sponsor
◉ Watch Acerand Therapeutics (Hong Kong) Limited
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer (NCT06801236) | Acerand Therapeutics (Hong Kong) Limited | 2025-05-12 |
Track Acerand Therapeutics (Hong Kong) Limited automatically
Every clearance here is in the API, with alerts when new ones post.